Ketamine clinical trials are underway in the U.S. The NIH is conducting a large-scale study, but smaller trials are taking place as well.

Previous studies only looked at the effects of ketamine on depression after a single infusion. Later studies evaluated the effects of multiple infusions, as well as the effect of Ketamine infusions on particular types of depression, such as PTSD, bipolar disorder and social anxiety. Additional studies have focused specifically on teens or alcoholics.

AKTARI is conducting its own clinical trials, which you can learn about here – Physicians Research Group – (  – PRG is the Clinical Research Study coordinator for AKTARI.